Go to BioCentury homepage
Print this Print this
Welcome to BCIQ: BioCentury Online Intelligence.
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange.

Please explore the profile and if you wish to find out more about BCIQ - please Click Here

Baxter International Inc.

Print preview Print preview

(NYSE:BAX)

Collapse Summary

General Information
 Location Deerfield, Ill.
 Region Midwest
 Country U.S.
 Business Category Pharmaceuticals
 Year Founded 1931
 Website www.baxter.com
 Development Status Market (drug) (08/02/2006)

Archive Items are loading
Collapse Summary

Pipeline Information
Disease CategoryResearchPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cardiovascular

1

1

1

1

-

-

-

1

1

Dermatology

-

-

-

1

-

-

-

-

1

Endocrine

-

1

-

-

-

-

-

-

-

Hematology

3

-

-

-

-

-

-

-

8

Infectious

-

-

-

-

-

-

-

2

2

Inflammation

-

1

-

-

-

-

-

-

-

Musculoskeletal

-

2

-

3

-

-

-

1

3

Neurology

-

-

-

1

-

1

-

1

-

Other

-

1

-

-

-

-

-

1

-

Renal

-

-

-

-

-

-

-

-

3

Transplant

-

-

-

-

-

-

-

-

1

Total

4

6

1

6

-

1

-

6

19

Pipeline Details - Originated and out-licensed products (23 records)

Product Names

Disease Category

Standard Indication

Partners

Milestones

Latest Stage of Development

ADAMTS-13 (Informal)

Cardiovascular

Thrombosis

 

 

Preclinical

Advate (Brand), Recombinant Factor VIII (Brand), rAHF-PFM (Compound #), octocog alfa (Generic), Advate (Informal), Factor VIII - protein-free method (rAHF-PFM) (Informal)

Hematology

Hemophilia

 

 

Marketed
More

Pipeline Details - In-licensed products (21 records)

Product NamesDisease CategoryStandard IndicationIn-licensed fromMilestonesLatest Stage of DevelopmentRights

ACAM2000 (Compound #)

Infectious

Smallpox

sanofi-aventis Group

 

Approved

Development

Adept (Brand), icodextrin (Generic), Adept (Other)

Musculoskeletal

Adhesions

Vectura Group plc

 

Marketed

Commercialization
More